-+ 0.00%
-+ 0.00%
-+ 0.00%

ConvaTec raises FY26 organic revenue growth outlook excluding InnovaMatrix to 6.25%-7.0%

PUBT·11/18/2026 07:05:33
Listen to the news
ConvaTec raises FY26 organic revenue growth outlook excluding InnovaMatrix to 6.25%-7.0%
  • ConvaTec raised FY26 organic revenue growth guidance excluding InnovaMatrix to 6.25-7% from 5.5-6.5%.
  • Organic revenue rose 6.6% excluding InnovaMatrix in the ten months ended October 31, 2026; reported growth reached 4.8%.
  • Infusion Care growth expectations increased to double digits from high single digits; Continence Care guidance rose to mid-to-high single digits.
  • Adjusted operating margin guidance remained at least 23%, with double-digit adjusted earnings per share growth still expected.
  • Equity cash conversion guidance fell to approximately 90% from approximately 100%, reflecting higher cash taxes and adjusting items.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ConvaTec Group plc published the original content used to generate this news brief on November 18, 2026, and is solely responsible for the information contained therein.